Published guidance, NICE advice and quality standards | Guidance

Showing 571 to 580 of 890

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer	TA531	18 July 2018	18 July 2018
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy	TA530	4 July 2018	4 July 2018
Beta interferons and glatiramer acetate for treating multiple sclerosis	TA527	27 June 2018	27 June 2018
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	TA217	23 March 2011	20 June 2018
Arsenic trioxide for treating acute promyelocytic leukaemia	TA526	13 June 2018	13 June 2018
Guselkumab for treating moderate to severe plaque psoriasis	TA521	13 June 2018	13 June 2018
Midostaurin for untreated acute myeloid leukaemia	TA523	13 June 2018	13 June 2018
Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma	TA524	13 June 2018	13 June 2018
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy	TA525	13 June 2018	13 June 2018
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy	TA520	16 May 2018	16 May 2018